Serotonin syndrome in a patient with dual diagnosis: Case study

Author:

Cvjetković Bošnjak,Bibić Željko,Kuljančić Dušan

Abstract

Introduction: Serotonin syndrome is a rare but potentially life-threatening condition. In most cases, this complication is caused by taking two serotonergic medications simultaneously, leading to excessive serotonin concentration in the body. Selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SNRIs), as well as irreversible monoamine oxidase inhibitors (MAOIs) and their combination with other serotonergic substances, are associated with symptoms of serotonin syndrome. Case study: A patient who was prescribed sertraline (an SSRI) for a depressive episode suffered fractures in a traffic accident during the treatment, and tramadol was prescribed for her pain. Since both drugs tend to increase serotonin levels in the body, a complication in the form of serotonin syndrome developed. With timely recognition and treatment, the symptoms of serotonin syndrome resolved without lasting consequences. Conclusion: Numerous drugs and substances can induce serotonin syndrome, often in combination with antidepressants. Therefore, it is of great importance that doctors are aware of comorbid conditions that necessitate the use of the mentioned drugs in order to prevent serotonin syndrome. If it does occur, adequate and successful treatment is crucial.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Reference22 articles.

1. Fricchione GL, Beach SR, Huffman JC, Bush G, Stern TA. Life-threatening conditions in psychiatry: catatonia, neuroleptic malignant syndrome and serotonin syndrome. In: Stern TA, Fava M, Wilens TE, Rosenbaum JF, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed., 2015;

2. Meehan TJ. Care of the poisoned patient. In: Walas RM, Hockberger RS, Gausche Hill M, eds Rosens Emegency Medicine: Concepts and Clinical Practice. 10 th .ed. Philadelphia PA: Elsevier; 2023: chap 135. doi: 10.5070/M561051830;

3. Sporer KA. The Serotonin Syndrome. Implicated drugs, pathophysiology and management. Drug Saf. 1995; 13(2): 94-104. doi: 10.2165/00002018-199513020-00004;

4. Dunkley EJ, Isbister GK, Sibri HD, Dawson AH,Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. OJM. 2003; 96 (9): 635-42. doi: 10.1093/qjmed/hcg109;

5. Gillman PK. The serotonin syndrome and its treament. J. Psychopharmacol. 1999 (Oxford); 13(1): 100-9. doi: 10.1177/026988119901300111;

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3